#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Wiskott-Aldrich syndrome Shprintzen-Goldberg syndrome Alport's syndrome Red blood cell abnormality Oesophageal achalasia Leukaemia Noonan syndrome Uterine leiomyosarcoma Laryngeal squamous cell carcinoma Pyruvate kinase deficiency anaemia Thalassaemia alpha Prolymphocytic leukaemia Biliary neoplasm Chronic graft versus host disease in skin Paroxysmal nocturnal haemoglobinuria More trials…

    Learn about Rare Diseases

    Krabbe’s disease – Trials in Disease Alternating hemiplegia of childhood – Treatment Hepatic angiosarcoma – Trials in Disease Mantle cell lymphoma stage IV – Basic Information Richter’s syndrome – Diagnostics Sarcoma – Basic Information Ocular melanoma – Basic Information Hereditary motor and sensory neuropathy – Basic Information Rett syndrome – Life with Disease Lymphangiosarcoma – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Transpocart19 Prasugrel Bicalutamide Paclitaxel Albumin-Bound Mr0005 Donanemab ATUMELNANT Ivacaftor Wt1 Lamp Mrna Dc Perampanel Fluoxetine Glucose, Anhydrous Noradrenaline Tartrate Riociguat Jab-21822 A49 Alpelisib Dacarbazine Citrate Orismilast Sufentanil Citrate More therapies…

    Learn about Your Condition

    Diabetic autonomic neuropathy Tardive dyskinesia Neuropathy peripheral Alcoholic liver disease Right ventricular dysfunction Renal cancer Aortic disorder Pemphigus Bacterial prostatitis Cardiovascular disorder Escherichia infection Epicondylitis Hypophosphatasia Affective disorder Choroid melanoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Digestive System Diseases

  • Study on the Effectiveness and Safety of RO7790121 for Patients with Moderate to Severe Crohn’s Disease

    Recruiting

    3 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Ro7790121
    Austria Belgium Bulgaria Croatia Czechia France +8

  • Study on Nivolumab and MesoPher for Patients with Peritoneal Mesothelioma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Peritoneal mesothelioma malignant
    Investigated Drugs:
    • AUTOLOGOUS DENDRITIC CELLS LOADED WITH ALLOGENIC ALLOGENEIC LYSATE OF MESOTHELIOMA CELL LINES
    • Nivolumab
    The Netherlands

  • Study on Vedolizumab and Ustekinumab for Patients with Crohn’s Disease and Ulcerative Colitis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Crohn’s disease
    • Colitis ulcerative
    Investigated Drugs:
    • Vedolizumab
    • Ustekinumab
    Denmark

  • Study on Preoperative Antibiotics for Patients with Acute Cholecystitis: Comparing Ertapenem, Ciprofloxacin, and Cefuroxime

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cholecystitis acute
    Investigated Drugs:
    • Ertapenem
    • Cefuroxime
    • Ciprofloxacin
    Finland

  • Study on the Effectiveness of Green Tea Extract and Trichloroacetic Acid for Treating Anal High-Grade Squamous Intraepithelial Lesions in Adults

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cervical dysplasia
    Investigated Drugs:
    • Camellia Sinensis (Green Tea) Leaf Extract
    Spain

  • Study on Hydrocortisone for Patients Undergoing Pancreatic Surgery

    Recruiting

    4 1 1
    Investigated Drugs:
    • Hydrocortisone
    • Sodium Chloride
    Germany
Previous Page
1 … 12 13 14 15 16 … 93
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!